Profitelligence Profitelligence · Filing Ledger Search all insiders →

Insider Profile · SEC Form 4 Activity · Trailing 90 Days

Klein Lawrence Otto

Over the trailing 90 days, Klein Lawrence Otto (Director at Oruka Therapeutics, Inc.) sold $120K of stock across 2 companies, per 2 SEC Form 4 transactions.

Role
Director
Companies
ORKA JBIO
Window
Trailing 90 days · 2 transactions · CIK 1762583
Net activity
−$120K ($0 bought · $120K sold)

By Company (Trailing 90 Days)

SymbolCompanyTxnsBoughtSoldNet
ORKAOruka Therapeutics, Inc.1$120K−$120K
JBIOJade Biosciences, Inc.1$0

Transactions (2)

DateSymbolTypeSharesValueDescription
2026-06-15ORKASell1.7K$120KOpen market or private sale
2026-06-09JBIOBuy34.8K$0Grant, award or other acquisition

Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.

Follow Klein's next move

Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.

Start free